Answers are grounded in this paper and cite their sources.
Chromosomal studies were performed on 61 adult patients with "typical chronic myelocytic leukemia. The Philadelphia (Ph1) chromosome was found in 43 patients, with equal sex distribution and with a median age of 48 years. The 18 Ph1-negative (Ph1-) patients had a median age of 66 years and were predominantly male. Absent leukocyte alkaline phosphatase was noted with equal frequency in both groups. The Ph1- patients had lower white blood cell and platelet counts and did not respond as well to antileukemic therapy. Basophilia and abnormally high platelet counts were fairly common among Ph1-positive (Ph1+) patients. The incidence of blastic crisis was approximately 50% in both groups but appeared earlier in the Ph1-negative patients. Median survival of Ph1+ patients was 40 months; that of the Ph1- group, only 8. Karyotypic analysis furnishes a subclassification of myelocytic leukemia with significant prognostic and therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Ediz Z. Ezdinli (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: